Fingolimod for adults with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies whether fingolimod can improve diabetes in adults with type 2 diabetes who are not yet on many medications. It will mainly check whether the drug is safe and whether it can help control blood sugar over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- You have been diagnosed with type 2 diabetes (not type 1).
- Your recent diabetes blood test (HbA1c) is between 6.5% and 9.5%.
- Your fasting blood sugar is not too high (different limits depending on whether you take diabetes pills).
- You can take part if you are not on diabetes medicine, or if your diabetes pills and dose have been stable for 3 months.
- Your BMI is 45 or less, and you agree to the study by signing consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called digoxin can help slow down aging-related cell changes in people with both heart failure and type 2 diabetes. If you qualify, you may receive a treatment that could improve your heart health.
This study checks how safe and effective fingolimod is when adults with relapsing-remitting multiple sclerosis start it for the first time. It may help confirm whether this treatment works well and is tolerated in newly treated patients.
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This study tracks how Greek patients with relapsing-remitting multiple sclerosis (RRMS) respond to fingolimod (Gilenya) over time. By collecting data from your routine care, researchers hope to learn more about the real-world effectiveness and safety of this medication.
This study tests an oral capsule called dimethyl fumarate to see if it can help preserve the body’s own insulin production in adults with type 1 diabetes. It may offer a way to slow the loss of beta cells and reduce reliance on insulin.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.